CRISPR Therapeutics AG (CRSP)
38.70
-1.49
(-3.71%)
USD |
NASDAQ |
Nov 19, 16:00
38.66
-0.04
(-0.10%)
After-Hours: 20:00
CRISPR Therapeutics Price : 38.70 for Nov. 19, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 18, 2026 | 40.25 | 42.66 | 40.10 | 40.19 | 3.979M |
| Nov 17, 2026 | 40.11 | 41.17 | 39.80 | 40.15 | 4.110M |
| Nov 16, 2026 | 41.49 | 42.19 | 39.83 | 40.37 | 2.395M |
| Nov 13, 2026 | 42.50 | 42.78 | 41.75 | 42.24 | 1.874M |
| Nov 12, 2026 | 45.09 | 45.09 | 42.38 | 42.62 | 2.493M |
| Nov 11, 2026 | 45.97 | 46.31 | 44.49 | 45.75 | 2.680M |
| Nov 10, 2026 | 49.02 | 49.29 | 44.99 | 45.15 | 4.014M |
| Nov 09, 2026 | 50.57 | 51.52 | 48.69 | 50.04 | 1.060M |
| Nov 06, 2026 | 48.98 | 50.27 | 48.41 | 50.07 | 1.235M |
| Nov 05, 2026 | 51.01 | 51.21 | 47.76 | 48.56 | 2.153M |
| Nov 04, 2026 | 51.48 | 52.50 | 50.19 | 51.78 | 1.394M |
| Nov 03, 2026 | 50.26 | 51.86 | 49.62 | 49.99 | 1.292M |
| Nov 02, 2026 | 51.90 | 52.12 | 49.70 | 49.99 | 1.026M |
| Oct 30, 2026 | 53.27 | 54.10 | 50.60 | 51.42 | 1.168M |
| Oct 29, 2026 | 54.11 | 55.82 | 53.30 | 54.26 | 1.314M |
| Oct 28, 2026 | 50.48 | 54.17 | 50.10 | 54.11 | 1.135M |
| Oct 27, 2026 | 49.14 | 51.55 | 48.75 | 51.47 | 1.167M |
| Oct 26, 2026 | 49.35 | 50.11 | 48.65 | 49.01 | 1.067M |
| Oct 23, 2026 | 49.31 | 49.68 | 48.02 | 49.39 | 1.926M |
| Oct 22, 2026 | 50.14 | 51.05 | 49.36 | 49.99 | 906107.0 |
| Oct 21, 2026 | 50.13 | 50.94 | 49.55 | 50.50 | 1.171M |
| Oct 20, 2026 | 48.87 | 50.33 | 47.36 | 49.88 | 2.156M |
| Oct 19, 2026 | 49.83 | 50.30 | 49.09 | 50.04 | 1.177M |
| Oct 16, 2026 | 51.20 | 51.36 | 49.04 | 49.25 | 1.525M |
| Oct 15, 2026 | 50.00 | 52.37 | 49.76 | 51.52 | 1.353M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Vertex Pharmaceuticals, Inc. | 520.68 |
| Basilea Pharmaceutica AG | 84.00 |
| Santhera Pharmaceuticals Holding AG | 18.30 |
| BeOne Medicines Ltd. | 399.38 |
| Intellia Therapeutics, Inc. | 9.54 |
Price Related Metrics
| PS Ratio | 147.81 |
| Price to Book Value | 2.274 |
| Earnings Yield | -12.27% |
| Market Cap | 3.748B |